Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cazes

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Soins; La Revue De Reference Infirmiere|May 20, 1980
[Madame G.' biliary calculi]M Cazes, M Marsault
Archives Internationales De Pharmacodynamie Et De Therapie|June 1, 1984
Effects of cibenzoline, a novel antiarrhythmic drug, on action potential and transmembrane currents in frog atrial muscleC Masse, M Cazes, A Sassine
Bulletin Des Societes D'Ophtalmologie De France|May 1, 1984
[Faden-operation in organic visual deficient children]R Pigassou Albouy, M Lagarrigue, M Cazes
European Journal of Pharmacology|September 15, 1995
In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonistM Cazes, D Provost, A Versigny, et al.
Journal of Medicinal Chemistry|January 1, 1986
[p-[(Thienylcarbonyl)amino]phenoxy]propanolamines derivatives as diuretic and beta-adrenergic receptor blocking agentsE Bouley, J M Teulon, M Cazes, et al.
British Journal of Pharmacology|February 1, 1997
In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferationA Virone-Oddos, V Desangle, D Provost, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|June 1, 1984
Cardiac electrophysiological effects of cibenzoline by acute and chronic administration in the anesthetized dogA Sassine, C Massé, A Dufour, et al.
Journal of Medicinal Chemistry|November 13, 1992
Cardiotonic agents. Synthesis and cardiovascular properties of novel 2-arylbenzimidazoles and azabenzimidazolesT Güngör, A Fouquet, J M Teulon, et al.
Fundamental & Clinical Pharmacology|January 1, 1995
In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonistF Caussade, A Virone-Oddos, C Delchambre, et al.
American Journal of Hypertension|March 1, 1997
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathyE Villa, A Rábano, M Cazes, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Soins; La Revue De Reference Infirmiere|May 20, 1980
[Madame G.' biliary calculi]M Cazes, M Marsault
Archives Internationales De Pharmacodynamie Et De Therapie|June 1, 1984
Effects of cibenzoline, a novel antiarrhythmic drug, on action potential and transmembrane currents in frog atrial muscleC Masse, M Cazes, A Sassine
Bulletin Des Societes D'Ophtalmologie De France|May 1, 1984
[Faden-operation in organic visual deficient children]R Pigassou Albouy, M Lagarrigue, M Cazes
European Journal of Pharmacology|September 15, 1995
In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonistM Cazes, D Provost, A Versigny, et al.
Journal of Medicinal Chemistry|January 1, 1986
[p-[(Thienylcarbonyl)amino]phenoxy]propanolamines derivatives as diuretic and beta-adrenergic receptor blocking agentsE Bouley, J M Teulon, M Cazes, et al.
British Journal of Pharmacology|February 1, 1997
In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferationA Virone-Oddos, V Desangle, D Provost, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|June 1, 1984
Cardiac electrophysiological effects of cibenzoline by acute and chronic administration in the anesthetized dogA Sassine, C Massé, A Dufour, et al.
Journal of Medicinal Chemistry|November 13, 1992
Cardiotonic agents. Synthesis and cardiovascular properties of novel 2-arylbenzimidazoles and azabenzimidazolesT Güngör, A Fouquet, J M Teulon, et al.
Fundamental & Clinical Pharmacology|January 1, 1995
In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonistF Caussade, A Virone-Oddos, C Delchambre, et al.
American Journal of Hypertension|March 1, 1997
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathyE Villa, A Rábano, M Cazes, et al.
Pageof 2